M&A Deal Summary

Haemonetics Acquires Pall - Transfusion Medicine Business

On August 1, 2012, Haemonetics acquired medical products company Pall - Transfusion Medicine Business from Pall for 551M USD

Acquisition Highlights
  • This is Haemonetics’ 4th transaction in the Medical Products sector.
  • This is Haemonetics’ largest (disclosed) transaction.
  • This is Haemonetics’ 9th transaction in the United States.

M&A Deal Summary
Date 2012-08-01
Target Pall - Transfusion Medicine Business
Sector Medical Products
Buyer(s) Haemonetics
Sellers(s) Pall
Deal Type Divestiture
Deal Value 551M USD

Target

Pall - Transfusion Medicine Business

United States
Pall's Transfusion Medicine Business is a blood collection, filtration and processing product lines.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Haemonetics

Boston, Massachusetts, United States

website

Category Company
Founded 1971
Sector Medical Products
Employees2,708
Revenue 993M USD (2022)
DESCRIPTION

Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for our customers. Company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 10 of 15
Sector (Medical Products) 4 of 8
Type (Divestiture) 1 of 1
Country (United States) 9 of 12
Year (2012) 1 of 1
Size (of disclosed) 1 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-01 Global Med Technologies

El Dorado Hills, California, United States

Global Med Technologies, Inc. is a healthcare information technology company which markets a breadth of software solutions and services that span the blood supply continuum, from blood collection to the hospital transfusion center to the patient care environment.

Buy $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-01 Hemerus Medical

St. Paul, Minnesota, United States

Hemerus Medical LLC is a technologies for the collection of whole blood, and processing and storage of blood components. Hemerus has completed Phase 3 clinical trials and has submitted a New Drug Application to the FDA for its unique, patented SOLX® whole blood collection system.

Buy $27M

Seller(S) 1

SELLER

Pall

Port Washington, New York, United States

website

Category Company
Founded 1946
Sector Manufacturing
Employees10,400
Revenue 2.8B USD (2014)
DESCRIPTION

Pall Corp. is a provider of filtration, separation and purification products to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 2
Country (United States) 1 of 2
Year (2012) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-19 ForteBio

Menlo Park, California, United States

ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-20 ATMI- LifeSciences Business

United States

ATMI- LifeSciences Business is a technology provider in the field of single use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries.

Buy $185M
Mergr

Product

Company

Legal